Analyst Reco. QuidelOrtho Corporation

Equities

QDEL

US2197981051

Market Closed - Nasdaq Other stock markets 04:30:00 2024-05-03 pm EDT			5-day change	1st Jan Change
42.5 ^USD	+0.66%		+7.21%	-42.33%

May. 02	QuidelOrtho Corporation Announces CEO Changes	CI
May. 02	QuidelOrtho Corporation Appoints Brian J. Blaser as President and to the Board	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

UBS Downgrades QuidelOrtho to Sell From Neutral, Adjusts Price Target to $42 From $70	Mar. 04	MT
William Blair Downgrades QuidelOrtho to Market Perform From Outperform	Feb. 14	MT
Citigroup Adjusts Price Target on QuidelOrtho to $50 From $72, Maintains Neutral Rating	Feb. 14	MT
Craig-Hallum Downgrades QuidelOrtho to Hold From Buy, Adjusts Price Target to $50 From $158	Feb. 14	MT
Raymond James Downgrades QuidelOrtho to Outperform From Strong Buy, Cuts Price Target to $76 From $100	Feb. 14	MT
JPMorgan Downgrades QuidelOrtho to Underweight From Neutral, Adjusts Price Target to $37 From $66	Feb. 14	MT
RBC Adjusts PT on QuidelOrtho to $81 From $130, Notes Worse-Than-Anticipated COVID Headwinds; Outperform Kept on 'Compelling' Risk/Reward	Feb. 14	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $140, Keeps Outperform Rating	Dec. 21	MT
Citigroup Downgrades QuidelOrtho to Neutral From Buy, Cuts Price Target to $72 From $95	Dec. 11	MT
Raymond James Adjusts QuidelOrtho's Price Target to $110 From $130, Keeps Strong Buy Rating	23-08-15	MT
RBC Raises QuidelOrtho's Price Target to $136 From $133, Keeps Outperform Rating	23-07-17	MT
UBS Adjusts QuidelOrtho Price Target to $98 From $99, Maintains Neutral Rating	23-05-17	MT
RBC Boosts Price Target on QuidelOrtho to $133 From $130, Maintains Outperform Rating	23-05-04	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $136, Maintains Outperform Rating	23-04-14	MT
RBC Cuts Price Target on QuidelOrtho to $130 From $136, Maintains Outperform Rating	23-04-13	MT
UBS Adjusts QuidelOrtho Price Target to $99 From $93, Maintains Neutral Rating	23-02-22	MT
Raymond James Cuts QuidelOrtho's Price Target to $130 From $136, Maintains Strong Buy Rating	23-02-16	MT
RBC Raises Price Target on QuidelOrtho to $136 From $125 After 'Strong' Q4, Above-Street 2023 Guidance, Maintains Outperform Rating	23-02-16	MT
Citigroup Upgrades QuidelOrtho to Buy From Neutral, Adjusts Price Target to $125 From $90	22-12-12	MT
RBC Initiates QuidelOrtho at Outperform With $125 Price Target, Sees Potential for Market Share Gains, Sales Acceleration Beyond 2024	22-12-07	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. QuidelOrtho Corporation

Equities

QDEL

US2197981051

Analyst Reco.

Filters